ClariPi

11 Ihwajang 1-gil, Jongno-gu, Seoul, 03088, South Korea  All South Korea companies → — Founded 2015
Imaging AI Specialist
Oncology Pulmonology Radiology
Oncology AI Radiology & Imaging AI
Later Stage VC (Series C) — $6.25M

Products

ClariPulmo
ClariPi
Oncology AI
ClariPulmo is a non-invasive image analysis software for use with CT images which is intended to support the quantification of lung CT images. The software is designed to support the physician in the diagnosis and documentation of pulmonary tissue images (e.g., abnormalities) from the CT thoracic datasets.
ClariSIGMAM
ClariPi
Oncology AI
ClariSIGMAM is an AI-powered breast density assessment solution by ClariPi that provides accurate and consistent density estimates from digital mammograms, aiding radiologists in breast tissue composition assessment and breast cancer risk prediction.
ClariCT.AI
ClariPi
Radiology & Imaging AI
ClariCT.AI is an FDA-cleared, AI-powered CT image denoising solution by ClariPi, enhancing clarity for low-dose and ultra-low-dose CT scans to improve diagnostic confidence and patient safety.

See all 3 products →

About ClariPi

ClariPi is a healthcare AI company specializing in innovative medical imaging solutions that leverage deep learning and big data technologies to address unmet needs in the field. Their core mission is to enhance patient safety by enabling significantly reduced radiation doses in CT scans while maintaining or improving diagnostic image quality.

For physicians, ClariPi’s products are designed to facilitate more confident and accurate diagnostic decisions by providing clearer information and convenient decision guidance. Their flagship product, ClariCT.AI, is a vendor-neutral CT denoising solution that utilizes a deep-learned Clarity Engine to clear image noise and enhance underlying anatomical structures, making ultra-low-dose CT images comparable to high-dose CT images. This technology integrates seamlessly into existing clinical workflows, compatible with any DICOM-compliant CT scanner and PACS system.

Beyond CT denoising, ClariPi offers a suite of AI-powered solutions for various diagnostic applications. These include ClariPulmo for 3D lung reporting and analysis of conditions like emphysema and COVID-19 pneumonia, ClariSIGMAM for precise breast density assessment, ClariAdipo for automated abdominal fat analysis, ClariOsteo for precision bone health analysis (osteoporosis and fracture risk), and ClariACE for augmented contrast enhancement in low-dose CECT images. These tools aim to streamline radiologists’ workflows, minimize time-consuming tasks, and provide quantitative analysis to assist in diagnosis, monitoring, and treatment planning.

Focus Areas

AI medical imaging deep learning CT denoising ultra-low-dose CT lung cancer screening emphysema diagnosis breast density analysis abdominal metabolic syndrome liver fat analysis bone health contrast enhancement

Business Intelligence

Key InvestorsSamho Green Investment, Korea AI Startup 100, Kbridge Ventures, Keistone Partners, Korea Investment Partners, Korea Investment Holdings
PartnershipsSiemens Healthineers Digital Marketplace, Nuance AI Marketplace, TeraRecon (ConcertAI company) Eureka Clinical AI Platform, Blackford Analysis
TechnologyDeep learning, convolutional neural networks, AI-powered image processing, big data computing, vendor-agnostic software, cloud-based distribution
FDA Clearances4 cleared products (estimated)

What Physicians Need to Know

AI Medical Imaging & Deep Learning
ClariPi specializes in AI-driven solutions for medical imaging, leveraging deep learning and convolutional neural networks. Their models are trained with over one million patient images to ensure robust performance and accuracy.
CT Denoising & Ultra-Low-Dose CT
ClariCT.AI, their flagship product, is an FDA-cleared and CE-marked AI-based CT denoising technology. It significantly reduces noise and enhances image clarity in low-dose and ultra-low-dose CT images, making them comparable to high-dose CTs while prioritizing patient safety.
Lung Cancer Screening & Emphysema Diagnosis
ClariPulmo is an AI-powered 3D reporting solution for lung CT images. It supports the quantification of lung tissue abnormalities, including low-attenuation and high-attenuation areas, aiding in the diagnosis and documentation of emphysema, COPD, and lung cancer screening.
Breast Density Analysis
ClariSIGMAM offers AI-powered breast density assessment from standard digital mammograms. It automatically analyzes fat and glandular tissue composition and provides breast density grades in line with the American College of Radiology's BI-RADS classification.
Abdominal Metabolic Syndrome & Liver Fat Analysis
ClariAdipo automatically measures subcutaneous and visceral fat density on abdominal CT images using AI. ClariMetabo provides opportunistic metabolic risk analysis, including abdominal and liver fat, muscle quality, and bone health.
Contrast Enhancement
ClariACE is the world's first AI-powered Augmented Contrast Enhancing solution for low-dose CECT images. It selectively boosts contrast agent components without increasing noise, offering clearer images even with reduced iodine doses.
Physician Tip

For physicians, ClariPi's solutions offer enhanced diagnostic confidence through superior image clarity, especially with ultra-low-dose CTs, which significantly improves patient safety by reducing radiation exposure. The vendor-neutral and DICOM-compliant nature of their products ensures seamless integration into existing workflows without requiring extensive hardware changes. Automated quantitative analysis for conditions like emphysema, breast density, and metabolic syndrome can streamline reporting and provide objective decision guidance, ultimately leading to more efficient and accurate diagnoses. Exploring their comprehensive suite of AI-powered tools can provide a holistic approach to various diagnostic challenges.

ClariPi's solutions are designed for broad compatibility, adhering to DICOM standards for seamless integration with any brand and model of CT scanner and PACS systems. Their products, such as ClariCT.AI, are available on major AI marketplaces, including Nuance AI Marketplace, Siemens Healthineers Digital Marketplace, Blackford Platform, and TeraRecon's Eureka Clinical AI platform, facilitating easy cloud-based distribution and deployment.

Products by ClariPi

3 products in the directory

ClariPulmo
ClariPi
Oncology AI
ClariPulmo is a non-invasive image analysis software for use with CT images which is intended to support the quantification of lung CT images. The software is designed to support the physician in the diagnosis and documentation of pulmonary tissue images (e.g., abnormalities) from the CT thoracic datasets.
ClariSIGMAM
ClariPi
Oncology AI
ClariSIGMAM is an AI-powered breast density assessment solution by ClariPi that provides accurate and consistent density estimates from digital mammograms, aiding radiologists in breast tissue composition assessment and breast cancer risk prediction.
ClariCT.AI
ClariPi
Radiology & Imaging AI
ClariCT.AI is an FDA-cleared, AI-powered CT image denoising solution by ClariPi, enhancing clarity for low-dose and ultra-low-dose CT scans to improve diagnostic confidence and patient safety.

Reviews & Opinions

No web reviews on file yet for ClariPi. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about ClariPi.

Loading videos...

Videos load interactively. If none appear, search YouTube for ClariPi →

View all on YouTube

Press & Coverage

PR Newswire
ConcertAI's TeraRecon Partners with ClariPi to Integrate AI Solutions for Comprehensive Medical Imaging on Eureka Clinical AI Platform
TeraRecon, a ConcertAI company, announced a strategic partnership with ClariPi to integrate ClariPi's AI solutions into its Eureka platform, aiming to enhance clinical workflows and deliver comprehensive medical imaging AI solutions globally. This collaboration will benefit healthcare providers by improving the efficiency and accuracy of radiology interpretation.
2023-07
ClariPi
Announces AI-based ultra-low dose CT solution to 'minimize medical radiation risk'
ClariPi announced its AI-based ultra-low dose CT solution, which aims to significantly reduce medical radiation risk. Clinical research has shown that this technology can reduce the radiation dose in pediatric CT scans by up to 1/20th.
2023-10
Imaging Technology News
ClariPi Joins Siemens Healthineers Digital Marketplace
ClariPi Inc. announced that its ClariCT.AI software will be available on Siemens Healthineers' Digital Marketplace, providing an open and secure environment for healthcare stakeholders to access and analyze data. This integration aims to simplify implementation and provide easy access to ClariPi's AI innovations for a large global user base.
2022-11
ClariPi
ClariPi, '3D Ultra-Low-Dose CT Imaging Technology' Acquired US FDA Approval
ClariPi announced that its product, ClariPulmo, a 3D ultra-low-dose CT imaging technology, obtained sales approval from the US Food and Drug Administration (FDA). ClariPulmo is a non-invasive image analysis software for use with CT images to aid in the assessment of lung abnormalities.
2022-04
Imaging Technology News
ClariPi Joins Nuance AI Marketplace for Ultra-Low-Dose CT Image Denoising Solution
ClariPi Inc. announced that its ClariCT.AI software is available on the Nuance AI Marketplace, offering a vendor-neutral CT denoising solution based on deep learning technology. This FDA-cleared and CE-marked software significantly increases CT image clarity, even with ultra-low-dose CTs.
2021-10
PR Newswire
ClariPi to Showcase its AI Medical Imaging Solutions at RSNA 2021
ClariPi presented its AI-powered low-dose CT denoising solution, ClariCT.AI, and other innovative AI imaging solutions at RSNA 2021. The company also introduced ClariACE, a software-based iodine contrast boost solution, and ClariPulmo, an AI-powered 3D reporting solution for COVID-19 pneumonia and emphysema.
2021-11
PubMed Central (PMC)
Low-iodine-dose computed tomography coupled with an artificial intelligence-based contrast-boosting technique in children
A study published in June 2024 investigated the image quality of low-iodine-dose CT combined with an AI-based contrast-boosting technique (ClariACE by ClariPi) in pediatric abdominal CT. The study aimed to evaluate the effectiveness of ClariACE in enhancing contrast in low-contrast-dose CT scans in children.
2024-06
PubMed
Impact of Deep Learning 3D CT Super-Resolution on AI-Based Pulmonary Nodule Characterization
A study published in January 2025, with contributions from ClariPi Research, explored the impact of a deep learning-based super-resolution technique on AI-based pulmonary nodule characterization. The research demonstrated that applying super-resolution to thick-slice CT images significantly increased the accuracy of pulmonary nodule volumetry and categorization.
2025-01

Frequently Asked Questions

ClariPi's flagship product, ClariCT.AI, utilizes deep learning and a 'Clarity Engine' to significantly reduce noise and enhance image clarity in low- and ultra-low-dose CT scans. This vendor-agnostic solution, trained on over a million patient images, aims to improve diagnostic confidence while minimizing patient radiation exposure.
For lung health, ClariPulmo provides AI-powered 3D reporting for emphysema and COPD, supporting lung cancer screening with ultra-low-dose CT by reducing noise-induced bias. ClariSIGMAM offers an AI-powered solution for accurate breast density measurement from digital mammograms, aiding in breast cancer risk assessment and compliance with density notification laws.
Yes, ClariAdipo automatically analyzes abdominal CT images to measure subcutaneous and visceral fat, helping predict metabolic syndrome risk. ClariOsteo is an AI-powered solution that uses existing CT scans to detect vertebral compression fractures and measure bone mineral density, providing insights into osteoporosis risk.
ClariACE is ClariPi's AI-powered augmented contrast enhancing solution for contrast-enhanced CT (CECT) images. It selectively boosts contrast agent components while denoising the data, aiming to improve image quality and potentially reduce the required contrast agent dose, thereby minimizing side effects.
Many of ClariPi's products, including ClariCT.AI, ClariPulmo, ClariSIGMAM, and ClariACE, are FDA-cleared and CE-marked, ensuring regulatory compliance for clinical use. Their solutions are vendor-agnostic and fully compliant with DICOM standards, allowing seamless integration with existing CT scanners and PACS systems, with options for cloud-based or on-premise deployment.
ClariPi, founded in 2015, is an AI medical imaging company that emphasizes collaboration with medical experts in product development. Their solutions are available through partnerships like the Nuance AI Marketplace, simplifying implementation and providing access to a broad user base.

Investors

Who's funded ClariPi.

Related Companies

Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]

Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]

Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]

Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]

Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]

SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.